C/M Capital Master Fund, LP 13D and 13G filings for Biodexa Pharmaceuticals Plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 4:18 pm Sale | 2025-06-30 | 13G | BIODEXA PHARMACEUTICALS INC SP BDRX | C/M Capital Master Fund, LP | 0 0.000% | -35,047,800 (Position Closed) | Filing |